Evidence map›Paper›PMID 37895289›Full record

ReviewGenes2023

Matthew S Alexander, Milen Velinov

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Matthew S AlexanderDepartment of Pediatrics, Division of Neurology, University of Alabama at Birmingham and Children's of Alabama, Birmingham, AL 35294, USA.ORCID 0000-0001-7406-5171
Milen VelinovDepartment of Pediatrics, Division of Genetics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.ORCID 0000-0002-0551-2019
Civitan International · USRutgers, The State University of New Jersey · US

Funding

UAB Pilot Center for Precision Animal Modeling (C-PAM) - Resource and Service SectionU54OD030167 · OD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Bradley K. Yoder · 2020 to 2026
$15.3M
A MIR-486/DOCK3 SIGNALING AXIS MODULATES DYSTROPHIN-DEFICIENT PATHOLOGYR01HD095897 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALEXANDER, MATTHEW SCOTT · 2018 to 2022
$1.6M
NICHD NIH HHS R01 HD095897NIH HHS U54 OD030167
6 · The paper itself

Abstract

The protein product of

Indexed as

Nerve Tissue ProteinsNeurodevelopmental DisordersGuanine Nucleotide Exchange FactorsHumansNeuronsSignal TransductionDOCK3 protein, humanGuanine Nucleotide Exchange FactorsNerve Tissue ProteinsDOCK3function of DOCK3genetic disorderneurodevelopmental disorder

Identifiers

PMID37895289
PMCPMC10606569
OpenAlexW4387638876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.